vs
Forestar Group Inc.（FOR）与Indivior Pharmaceuticals, Inc.（INDV）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是Forestar Group Inc.的1.3倍（$357.0M vs $273.0M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs 5.6%，领先23.2%），Forestar Group Inc.自由现金流更多（$-157.1M vs $-245.0M）
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
FOR vs INDV — 直观对比
营收规模更大
INDV
是对方的1.3倍
$273.0M
净利率更高
INDV
高出23.2%
5.6%
自由现金流更多
FOR
多$87.9M
$-245.0M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $273.0M | $357.0M |
| 净利润 | $15.4M | $103.0M |
| 毛利率 | 20.1% | 82.1% |
| 营业利润率 | 7.6% | 22.7% |
| 净利率 | 5.6% | 28.9% |
| 营收同比 | 9.0% | — |
| 净利润同比 | -6.7% | 390.5% |
| 每股收益（稀释后） | $0.30 | $0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORINDV
| Q4 25 | $273.0M | $357.0M | ||
| Q3 25 | $670.5M | $314.0M | ||
| Q2 25 | $390.5M | $302.0M | ||
| Q1 25 | $351.0M | $266.0M | ||
| Q4 24 | $250.4M | — | ||
| Q3 24 | $551.3M | $307.0M | ||
| Q2 24 | $318.4M | $299.0M | ||
| Q1 24 | $333.8M | — |
净利润FORINDV
| Q4 25 | $15.4M | $103.0M | ||
| Q3 25 | $86.9M | $42.0M | ||
| Q2 25 | $32.9M | $18.0M | ||
| Q1 25 | $31.6M | $47.0M | ||
| Q4 24 | $16.5M | — | ||
| Q3 24 | $81.5M | $22.0M | ||
| Q2 24 | $38.7M | $-97.0M | ||
| Q1 24 | $45.0M | — |
毛利率FORINDV
| Q4 25 | 20.1% | 82.1% | ||
| Q3 25 | 22.3% | 73.2% | ||
| Q2 25 | 20.4% | 82.8% | ||
| Q1 25 | 22.6% | 83.1% | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 23.9% | 78.5% | ||
| Q2 24 | 22.5% | 73.6% | ||
| Q1 24 | 24.9% | — |
营业利润率FORINDV
| Q4 25 | 7.6% | 22.7% | ||
| Q3 25 | 16.9% | 13.7% | ||
| Q2 25 | 11.2% | 23.8% | ||
| Q1 25 | 11.6% | 24.8% | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | 19.7% | 11.4% | ||
| Q2 24 | 16.2% | -39.5% | ||
| Q1 24 | 17.6% | — |
净利率FORINDV
| Q4 25 | 5.6% | 28.9% | ||
| Q3 25 | 13.0% | 13.4% | ||
| Q2 25 | 8.4% | 6.0% | ||
| Q1 25 | 9.0% | 17.7% | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 14.8% | 7.2% | ||
| Q2 24 | 12.2% | -32.4% | ||
| Q1 24 | 13.5% | — |
每股收益（稀释后）FORINDV
| Q4 25 | $0.30 | $0.79 | ||
| Q3 25 | $1.70 | $0.33 | ||
| Q2 25 | $0.65 | $0.14 | ||
| Q1 25 | $0.62 | $0.38 | ||
| Q4 24 | $0.32 | — | ||
| Q3 24 | $1.59 | $0.16 | ||
| Q2 24 | $0.76 | $-0.72 | ||
| Q1 24 | $0.89 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $195.0M |
| 总债务越低越好 | $793.2M | — |
| 股东权益账面价值 | $1.8B | $-98.0M |
| 总资产 | $3.2B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.44× | — |
8季度趋势，按日历期对齐
现金及短期投资FORINDV
| Q4 25 | $211.7M | $195.0M | ||
| Q3 25 | $379.2M | $445.0M | ||
| Q2 25 | $189.2M | $510.0M | ||
| Q1 25 | $174.3M | $373.0M | ||
| Q4 24 | $132.0M | — | ||
| Q3 24 | $481.2M | — | ||
| Q2 24 | $359.2M | — | ||
| Q1 24 | $416.2M | — |
总债务FORINDV
| Q4 25 | $793.2M | — | ||
| Q3 25 | $802.7M | — | ||
| Q2 25 | $872.8M | — | ||
| Q1 25 | $872.5M | — | ||
| Q4 24 | $806.8M | — | ||
| Q3 24 | $706.4M | — | ||
| Q2 24 | $706.1M | — | ||
| Q1 24 | $705.7M | — |
股东权益FORINDV
| Q4 25 | $1.8B | $-98.0M | ||
| Q3 25 | $1.8B | $-207.0M | ||
| Q2 25 | $1.7B | $-257.0M | ||
| Q1 25 | $1.6B | $-285.0M | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | $-310.0M | ||
| Q2 24 | $1.5B | $-281.0M | ||
| Q1 24 | $1.5B | — |
总资产FORINDV
| Q4 25 | $3.2B | $1.2B | ||
| Q3 25 | $3.1B | $1.4B | ||
| Q2 25 | $3.1B | $1.5B | ||
| Q1 25 | $3.0B | $1.4B | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $2.8B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.6B | — |
负债/权益比FORINDV
| Q4 25 | 0.44× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.50× | — | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-157.0M | $-221.0M |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | $-245.0M |
| 自由现金流率自由现金流/营收 | -57.5% | -68.6% |
| 资本支出强度资本支出/营收 | 0.0% | 6.7% |
| 现金转化率经营现金流/净利润 | -10.19× | -2.15× |
| 过去12个月自由现金流最近4个季度 | $93.0M | $-93.0M |
8季度趋势，按日历期对齐
经营现金流FORINDV
| Q4 25 | $-157.0M | $-221.0M | ||
| Q3 25 | $256.3M | $-39.0M | ||
| Q2 25 | $15.8M | $158.0M | ||
| Q1 25 | $-19.8M | $75.0M | ||
| Q4 24 | $-450.0M | — | ||
| Q3 24 | $119.2M | $2.0M | ||
| Q2 24 | $-61.7M | $88.0M | ||
| Q1 24 | $-59.2M | — |
自由现金流FORINDV
| Q4 25 | $-157.1M | $-245.0M | ||
| Q3 25 | $255.6M | $-59.0M | ||
| Q2 25 | $15.0M | $141.0M | ||
| Q1 25 | $-20.5M | $70.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $118.4M | $-5.0M | ||
| Q2 24 | $-62.3M | $84.0M | ||
| Q1 24 | $-59.8M | — |
自由现金流率FORINDV
| Q4 25 | -57.5% | -68.6% | ||
| Q3 25 | 38.1% | -18.8% | ||
| Q2 25 | 3.8% | 46.7% | ||
| Q1 25 | -5.8% | 26.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | 21.5% | -1.6% | ||
| Q2 24 | -19.6% | 28.1% | ||
| Q1 24 | -17.9% | — |
资本支出强度FORINDV
| Q4 25 | 0.0% | 6.7% | ||
| Q3 25 | 0.1% | 6.4% | ||
| Q2 25 | 0.2% | 5.6% | ||
| Q1 25 | 0.2% | 1.9% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | 2.3% | ||
| Q2 24 | 0.2% | 1.3% | ||
| Q1 24 | 0.2% | — |
现金转化率FORINDV
| Q4 25 | -10.19× | -2.15× | ||
| Q3 25 | 2.95× | -0.93× | ||
| Q2 25 | 0.48× | 8.78× | ||
| Q1 25 | -0.63× | 1.60× | ||
| Q4 24 | -27.27× | — | ||
| Q3 24 | 1.46× | 0.09× | ||
| Q2 24 | -1.59× | — | ||
| Q1 24 | -1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
